Poliomyelitis: Concerns for polio-free countries

Vaccine

Volumn 25, Issue 17, 2007, Pages 3245-3246

  Arya, Subhash C ^a   Agarwal, Nirmala ^a  

^a SANT PARMANAND HOSPITAL   (India)

Author keywords

Dwindling immunity and vaccine derived polioviruses; Inactivated vaccine; Poliomyelitis; Vaccine performance

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ANTIBODY TITER; BIOLOGICAL WARFARE; DISEASE CONTROL; DISEASE PREDISPOSITION; ENDEMIC DISEASE; ENTEROVIRUS; GENE SEQUENCE; GENETIC STABILITY; GENETIC VARIABILITY; HERD IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; LETTER; MORBIDITY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PREVALENCE; PRIORITY JOURNAL; REVACCINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SEWAGE; VIRUS ISOLATION; VIRUS REPLICATION;

HUMANS; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; SEWAGE;

EID: 34047172669     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.039     Document Type: Letter

References (12)

1. MMWR Weekly. Update on vaccine-derived polioviruses. MMWR 55 40 (2006) 1093-1097
2. Gidding H.F., Backhouse J.L., Gilbert G.L., and Burgess M.A. National serosurvey of poliovirus immunity in Australia, 1996-99. Aust N Z J Public Health 29 1 (2005) 48-52
3. Frantzidou F., Diza E., Halkia D., and Antoniadis A. A seroprevalence study of poliovirus antibody in the population of northern Greece. Clin Microbiol Infect 11 (2005) 68-71
4. Pregliasco F., Minolfi V., Boschin A., Andreassi A., and Profeta M.L. A seroepidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts. Eur J Epidemiol 11 6 (1995) 693-695
5. Plans Rubio P., Rabella Garcia N., Otegui Zabalo M., Espunes Vendrell J., Dominguez Garcia A., and Plasencia Taradach A. Evaluation of the immunity level achieved with the oral polio vaccine in schoolchildren aged 6 to 12 years of Catalonia (Spain). Med Clin (Barc) 127 16 (2006) 612-614
6. Shulman L.M., Manor Y., Sofer D., Swartz T., and Mendelson E. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?. Isr Med Assoc J 8 (2006) 312-315
7. Joce R., Wood D., Brown D., and Brigg N. Paralytic poliomyelitis in England and Wales. BMJ 305 (1992) 79-82
8. Diedrich S., Claus H., and Schreier E. Immunity status against poliomyelitis in Germany: determination of cut-off values in international units. BMC Infect Dis 2 (2002) 2
9. Pavlov D.N. Poliovirus vaccine strains in sewage and river water in South Africa. Can J Microbiol 52 8 (2006) 717-723
10. Requirements for the production and control of poliomyelitis vaccine (inactivated). In: WHO Expert Committee on biological standardization. Fifty-first report. Geneva. WHO Technical Report series, vol. 910; 2002. p. 32-65 [Annex 3].
11. Dalton R. Health centers and labs left reeling by Katrina. Nature 437 (2005) 177
12. Macadam A.J., Ferguson G., Stone D.M., Meredith J., Knowlson S., Auda G., et al. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol 80 17 (2006) 8653-8663